Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Menglin Li und 25 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Nomograms, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Therapy-related acute myeloid leukemia (t-AML), which develops after cytotoxic therapy, has a poorer prognosis. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential cure, its efficacy varies among patients. In this retrospective study, we analyzed 154 patients with t-AML who underwent hematopoietic stem cell transplantation (HSCT) at our institution to determine their clinical characteristics and develop a prognostic nomogram. The median ages at t-AML diagnosis prior disease diagnosis was 42 and 39 years, respectively. Multivariate analysis identified key prognostic indicators: leukocyte count at AML diagnosis ≥7 × 10^9/L, genetic abnormalities before HSCT, platelet engraftment ≥28 days, age at prior disease ≥45 years, and relapse of prior disease. We developed a prognostic nomogram for LGPAR by categorizing patients into low, medium, and high-risk groups. The 3-year and 5-year overall survival (OS) rates for these groups were 92.6 %, 84.4 %, 14 %, and 92.6 %, 76.6 %, and 7 %, respectively. The 3-year and 5-year relapse-free survival (RFS) rates were 80 %, 75.9 %, 10.7 % and 80 %, 72.6 %, and 10.7 % for the respective risk groups. The 3-year and 5-year non-relapse mortality (NRM) rates were 0 %, 5.6 %, 63.3 % and 0 %, 9.3 %, and 63.3 % for these groups, respectively. This novel prognostic nomogram culminates in the development of a clinical decision-support tool for patients with t-AML undergoing allo-HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Peking University People's Hospital, Peking University Institute of Hematology, China.
- Peking University People's Hospital, Peking University Institute of Hematology, China. Electronic address: Zhangxh100@sina.com.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- Capital Health Research and Development of Special Fund
- Key Technologies Research and Development Program
Zitieren
APA
Li, M., Li, Y., Qu, Q., Wang, C., Chen, Q., Zhu, X., He, Y., Fu, H., Zhang, Y., Jiang, H., Jiang, Q., Zhao, X., Zhao, X., Chang, Y., Wang, F., Mo, X., Han, W., Wang, J., Chen, H., …, & Zhang, X. (2025). Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217460
Vancouver
Li M, Li Y, Qu Q, Wang C, Chen Q, Zhu X, et al. Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217460
BibTeX
@article{Li2025,
author = {Li, Menglin and Li, Yimeng and Qu, Qingyuan and Wang, Chencong and Chen, Qi and Zhu, Xiaolu and He, Yun and Fu, Haixia and Zhang, Yuanyuan and Jiang, Hao and Jiang, Qian and Zhao, Xiaosu and Zhao, Xiangyu and Chang, Yingjun and Wang, Fengrong and Mo, Xiaodong and Han, Wei and Wang, Jingzhi and Chen, Huan and Chen, Yuhong and Chen, Yao and Wang, Yu and Xu, Lanping and Liu, Kaiyan and Huang, Xiaojun and Zhang, Xiaohui},
title = {Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217460}
}
EUVIMED